Skip header and navigation

18 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Table Infectious Disease
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
May 18, 2022 What is known about hybrid immunity to COVID-19? INF220501 ESR Infectious Disease
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR Table EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
March 4, 2022 What is the safety/efficacy of the Novavax vaccine? EOC220302 ESR EOC
January 12, 2022 In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease? EOC211201 RR Table EOC
January 12, 2022 In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease? EOC211201 RR EOC
January 5, 2022 Omicron Variant: In real world settings, what is the validity of RATs in identifying COVID-19 (sensitivity, specificity), and how well do they predict disease (positive and negative predictive values)? EOC211201-02 ESR EOC
December 29, 2021 In real world settings, what is the validity of RATs in identifying COVID-19 (sensitivity, specificity), and how well do they predict disease (positive and negative predictive values)? EOC211201 ESR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR Table EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
August 27, 2020 What laboratory surveillance testing strategies are effective for COVID-19 in school settings? PH082501 RR Public Health
August 25, 2020 What laboratory surveillance testing strategies are effective for COVID-19 in school settings? PH082501-01 ESR Public Health

18 records – page 1 of 1.